跳至主要内容
临床试验/NCT01696708
NCT01696708已完成不适用

Study of the Brain Energy Profile Evolution, Using 31Phosphorus-Nuclear Magnetic Resonance Spectroscopy, at Different Stages of Huntington Disease

Institut National de la Santé Et de la Recherche Médicale, France1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年12月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Ratio of Inorganic Phosphate (Pi) over phosphocreatine (PCr): Pi/PCr

研究概览

简要总结

The purpose of this project is to study brain energy profile evolution at different stages of the Huntington disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •UHDRS < 50
  • •Age > 18 years
  • •Ability to undergo MR scanning
  • •Covered by french social security

排除标准

  • •Evidence of psychiatric disorder
  • •Attendant neurological disorder
  • •Contraindications to MRI (claustrophobia, metallic or material implants)
  • •Severe head injury
  • •Unable to understand the protocol
  • •Pregnancy
  • •Failure to give informed consent
  • •Subjects with exclusion criteria required by french law (e.g. subjects who require a legally authorized representative to obtain consent)
  • •Unwillingness to be informed in case of abnormal MRI

研究组 & 干预措施

Patients

Other

31-Phosphorus RMN Spectroscopy

干预措施: 31-Phosphorus RMN Spectroscopy (Other)

Volunteers

Other

31-Phosphorus RMN Spectroscopy

干预措施: 31-Phosphorus RMN Spectroscopy (Other)

结局指标

主要结局

Ratio of Inorganic Phosphate (Pi) over phosphocreatine (PCr): Pi/PCr

时间窗: 2 years

31P-MRS allows quantification of high-energy phosphate metabolites such as phosphocreatine and inorganic phosphate

次要结局

  • Correlation between primary outcome measure and clinical parameters(2 years)
  • Study of longitudinal changes in Pi/PCr ratio over time.(2 years)

研究者

发起方
Institut National de la Santé Et de la Recherche Médicale, France
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验